CP
AMPE

Camelot Portfolios’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Camelot Portfolios’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-120
Closed -$46K – 174
2016
Q2 		$46K Sell
120
-200
-63% -$218K 0.03% 161
2016
Q1 		$216K Hold
320
– – 0.13% 134
2015
Q4 		$336K Hold
320
– – 0.21% 106
2015
Q3 		$277K Hold
320
– – 0.19% 119
2015
Q2 		$228K Hold
320
– – 0.13% 147
2015
Q1 		$723K Buy
320
+67
+26% +$114K 0.42% 70
2014
Q4 		$261K Sell
253
-4
-2% -$4.27K 0.15% 132
2014
Q3 		$272K Buy
257
+72
+39% +$121K 0.16% 129
2014
Q2 		$463K Buy
185
+2
+1% +$4.08K 0.3% 94
2014
Q1 		$349K Buy
183
+3
+2% +$7.09K 0.24% 107
2013
Q4 		$385K Buy
180
+17
+10% +$40.2K 0.25% 100
2013
Q3 		$368K Buy
163
+41
+34% +$79.3K 0.27% 93
2013
Q2 		$212K Buy
+122
New +$194K 0.16% 126

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Camelot Portfolios's AMPE Position: Q3 2016 in Review

Camelot Portfolios sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2016, closing a stake of 120 shares — an estimated $46K sold.

Camelot Portfolios first reported a position in AMPE in Q2 2013 and held it in 13 quarters. The position peaked at $723K in Q1 2015. 71 funds tracked by Wall St. Rank hold AMPE as of Q3 2016.

  • Camelot Portfolios reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2016 after selling out during the quarter.
  • Camelot Portfolios sold 120 Ampio Pharmaceuticals Inc. shares in Q3 2016, an estimated $46K.
  • Camelot Portfolios first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and held it in 13 quarters.
  • Camelot Portfolios's Ampio Pharmaceuticals Inc. position peaked at $723K in Q1 2015.
  • 71 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2016.

Based on Camelot Portfolios's 13F filing for Q3 2016, filed 4 Nov 2016.